Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | KNSA | ACAD | ||
| Company | Akero Therapeutics Inc | Kiniksa Pharmaceuticals International Plc | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.52 | 62.86 | 25.41 | ||
| High | 54.83 | 64.57 | 26.23 | ||
| Low | 54.37 | 62.04 | 25.13 | ||
| Latest | 54.65 | 64.53 | 25.97 | ||
| Change | +0.10 | +1.65 | +0.77 | ||
| % Change | +0.18% | +2.62% | +3.06% | ||
| Volume | 15,312,200 | 626,200 | 1,586,300 | ||
| 20-Day Average Volume | 2,420,955 | 986,280 | 1,721,045 | ||
| Previous Close | 54.55 | 62.88 | 25.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.38 | 55.39 | 22.74 | ||
| 20-Day Raw Stochastic | 78.26% | 98.39% | 79.29% | ||
| 20-Day Relative Strength | 65.57 | 69.32 | 71.60 | ||
| Weighted Alpha | +16.80 | +112.55 | +25.02 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 12/01/25 | +13.43% since 06/25/26 | +9.49% since 06/25/26 | ||
| Low | 54.29 on 12/05/25 | 56.56 on 06/26/26 | 24.93 on 07/01/26 | ||
| High | 54.83 on 12/08/25 | 64.81 on 06/30/26 | 27.31 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +1.13% since 11/07/25 | +37.53% since 06/02/26 | +24.32% since 06/02/26 | ||
| Low | 54.02 on 11/10/25 | 47.24 on 06/03/26 | 20.76 on 06/03/26 | ||
| High | 54.83 on 12/08/25 | 64.81 on 06/30/26 | 27.31 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +22.62% since 09/08/25 | +32.18% since 04/02/26 | +16.98% since 04/02/26 | ||
| Low | 41.77 on 09/15/25 | 41.49 on 04/21/26 | 20.30 on 05/19/26 | ||
| High | 54.83 on 12/08/25 | 64.81 on 06/30/26 | 27.31 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +0.68% since 06/06/25 | +53.62% since 01/02/26 | -1.22% since 01/02/26 | ||
| Low | 41.77 on 09/15/25 | 37.02 on 01/15/26 | 19.89 on 03/19/26 | ||
| High | 57.35 on 06/27/25 | 64.81 on 06/30/26 | 27.81 on 01/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,499,006 | 4,964,810 | 4,446,999 | ||
| Shares Outstanding, K | 82,324 | 76,938 | 171,236 | ||
| Annual Sales | 0 | 677,560,000 | 1,071,510,000 | ||
| Annual Net Income | -252,060,000 | 59,010,000 | 391,000,000 | ||
| Last Quarter Sales | 0 | 214,270,000 | 268,060,000 | ||
| Last Quarter Net Income | -81,570,000 | 22,590,000 | 3,640,000 | ||
| 60-Month Beta | -0.40 | 0.07 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/07/25 | 0.27 on 04/28/26 | 0.02 on 05/06/26 | ||
| Earnings Date | 02/27/26 | 08/04/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 69.87 | 42.00 | ||